- Home
- PHAT vs JKS Comparison
PHAT vs JKS Comparison
Compare PHAT & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAT | JKS |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 969.8M | 1.0B |
| IPO Year | 2019 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PHAT | JKS |
|---|---|---|
| Price | $8.72 | $15.80 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | $19.83 | ★ $24.80 |
| AVG Volume (30 Days) | ★ 1.5M | 638.8K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 6.04% |
| EPS Growth | ★ 42.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $175,110,000.00 | N/A |
| Revenue This Year | $93.04 | N/A |
| Revenue Next Year | $58.91 | $14.60 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 216.93 | N/A |
| 52 Week Low | $8.03 | $14.55 |
| 52 Week High | $18.31 | $31.88 |
Technical Indicators
Market Signals| Indicator | PHAT | JKS |
|---|---|---|
| Relative Strength Index (RSI) | 33.84 | 45.72 |
| Support Level | $8.78 | $15.14 |
| Resistance Level | $13.17 | $17.34 |
| Average True Range (ATR) | 0.67 | 0.82 |
| MACD | -0.31 | 0.13 |
| Stochastic Oscillator | 13.98 | 42.65 |
Price Performance
Historical ComparisonAbout PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), the Americas, Europe, Asia Pacific, and the Rest of the world.